This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanford, H. A. Articles by Soff, G. A. Search for Related Content PubMed PubMed Citation Articles by Hanford, H. A. Articles by Soff, G. A.

Angiostatin_4.5-mediated Apoptosis of Vascular Endothelial Cells

Northwestern University Feinberg School of Medicine, Department of Medicine, Divisions of Hematology/Oncology [H. A. H., C. A. W., H. K., D. L. C., G. A. S.] and Pulmonary and Critical Care [N. C.], Chicago, Illinois 60611, and Division of Obstetrics and Gynaecology, Nottingham City Hospital, Nottingham, United Kingdom [S. U., C. A. M.]

Angiostatin, a proteolytic cleavage product of plasminogen, acts via a selective, yet poorly understood mechanism to potently inhibit angiogenesis (M. S. O’Reilly et al., Cell, 79: 315–328, 1994). Vascular endothelial cell proliferation assays revealed that angiostatin_4.5, a naturally occurring human isoform consisting of plasminogen kringle domains 1–4 and most of kringle domain 5 (G. A. Soff, Cancer Metastasis Rev., 19: 97–107, 2000), dose dependently reduces cell number despite the presence of a potent stimulus of proliferation. Flow cytometry using the vital dyes Hoechst 33342 and Pyronin Y revealed that 40% of both control and angiostatin_4.5-treated cells were in the proliferative phase, indicating that cell cycle progression is not impaired by exposure to angiostatin_4.5. Both bovine aortic endothelial cells and human umbilical endothelial cells were shown to undergo apoptosis in response to angiostatin_4.5. Caspases-3, -8, and -9 activation, specified by cleavage of fluorophore-conjugated specific peptide substrates, revealed a cascade of caspase activation that peaks at 36 h of angiostatin_4.5 treatment. Angiostatin_4.5 exposure induced release of cytochrome c from mitochondria in a caspase-dependent manner, but a pan-caspase inhibitor, zVAD-fmk, blocked cytochrome c release. Overall, these data indicate that human angiostatin_4.5 may function in vivo to block blood vessel formation by specifically inducing vascular endothelial cells to apoptose in a process likely involving both the intrinsic and extrinsic apoptosis pathways.

This article has been cited by other articles:

				K Yamahara, K D Min, H Tomoike, K Kangawa, S Kitamura, and N Nagaya Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation Heart, February 1, 2009; 95(4): 283 - 289. [Abstract] [Full Text] [PDF]

				B. Martinez-Poveda, R. Munoz-Chapuli, S. Rodriguez-Nieto, J. M. Quintela, A. Fernandez, M.-A. Medina, and A. R. Quesada IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo Mol. Cancer Ther., October 1, 2007; 6(10): 2675 - 2685. [Abstract] [Full Text] [PDF]

				V. Schmitz, E. Raskopf, M. A. Gonzalez-Carmona, A. Vogt, C. Rabe, L. Leifeld, M. Kornek, T. Sauerbruch, and W. H Caselmann Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model Gut, February 1, 2007; 56(2): 271 - 278. [Abstract] [Full Text] [PDF]

				K. Schmidt, J. Hoffend, A. Altmann, F. Kiessling, L. Strauss, D. Koczan, W. Mier, M. Eisenhut, R. Kinscherf, and U. Haberkorn Troponin I Overexpression Inhibits Tumor Growth, Perfusion, and Vascularization of Morris Hepatoma J. Nucl. Med., September 1, 2006; 47(9): 1506 - 1514. [Abstract] [Full Text] [PDF]

				H. Wang, J. A. Doll, K. Jiang, D. L. Cundiff, J. S. Czarnecki, M. Wilson, K. M. Ridge, and G. A. Soff Differential Binding of Plasminogen, Plasmin, and Angiostatin4.5 to Cell Surface {beta}-Actin: Implications for Cancer-Mediated Angiogenesis. Cancer Res., July 15, 2006; 66(14): 7211 - 7215. [Abstract] [Full Text] [PDF]

				K. Schmidt, J. Hoffend, A. Altmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, B. Engelhardt, D. Koczan, J. Peter, T. J. Dengler, W. Mier, et al. Angiostatin Overexpression in Morris Hepatoma Results in Decreased Tumor Growth but Increased Perfusion and Vascularization J. Nucl. Med., March 1, 2006; 47(3): 543 - 551. [Abstract] [Full Text] [PDF]

				G. A. Soff, H. Wang, D. L. Cundiff, K. Jiang, B. Martone, A. W. Rademaker, J. A. Doll, and T. M. Kuzel In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna Clin. Cancer Res., September 1, 2005; 11(17): 6218 - 6225. [Abstract] [Full Text] [PDF]